

Larazotide 10mg
Larazotide research compound. Supplied as a lyophilized peptide reference material for laboratory research applications.
For laboratory research use only. Not for human or veterinary use.
- Buy 2+ for $118.33 each and save 3%
- Buy 3+ for $115.89 each and save 5%
- Buy 5+ for $109.79 each and save 10%
- Buy 10+ for $103.69 each and save 15%
Direct from manufacturer to researcher
Shipping options confirmed at checkout
For laboratory research only

NEWAdvanced Laboratory Testing
Characteristics
| Molecular Formula | C32H55N9O10 |
|---|---|
| CAS | 258818-34-7 |
| Molar Mass | 725.8 g/mol |
| Chemical Formula | C34H59N9O12 |
| Amino Acid Sequence | GGVLVQPG |
| Synonyms | Larazotide, Larazotide acetate, AT-1001 |
| Solubility | Water-soluble |
| Organoleptic Profile | White to off-white powder |
| Composition | Lyophilized peptide powder - requires reconstitution |
Handling & Safety
Handle according to the product label and your laboratory’s safety procedures. Wear appropriate protective equipment. Store in a cool, dry place protected from light. For laboratory research use only. Not for human or veterinary use.
Summary
Larazotide 10 mg is a synthetic peptide supplied exclusively for research and laboratory use. Its defined amino acid sequence, solubility profile, and standardized lyophilized format make it suitable for controlled experimental workflows involving epithelial cell systems. Researchers utilize this peptide within in vitro and preclinical models where consistency, reproducibility, and experimental comparability are essential to peptide-cell interaction studies. Research context only. No human or veterinary use.
Certificate of Analysis (COA)
Resource
All products on this site are for research and development use only. Products are not for human consumption of any kind. Neither the statements nor the products offered are intended to diagnose, treat, cure, or prevent any disease.
Peptide Research Insights
From the discoveries of 1977 to the next chapter in peptide science.
Explore research insights


